Eight years away from the Sustainable Development Goals (SDGs) targets, the United Nations Inter-agency Group for Child Mortality Estimation (UN IGME) database suggests that 63 countries are currently off track to meet this target, noting that no country will reach the SDGs without providing quality small and sick newborn care (SSNC) at the level-2 facility level, including high-impact interventions for the management of respiratory distress. Providing safe oxygen and effective pressures to newborns with respiratory distress and pneumonia is critical to provide quality care to 30 million newborns requiring inpatient care each year. World Health Organization (WHO) standards call for specific medical equipment appropriate for SSNC. In response, global innovators have designed equipment for respiratory support that provides effective pressure generation, blended oxygen, and oxygen saturation monitoring to prevent oxygen toxicity in premature newborns.

The Every Newborn Action Plan set national targets for 2025: 80% of districts to have at least one functional level-2 inpatient unit for small and sick newborns (SSNBs), including continuous positive airway pressure (CPAP). To guide countries' efforts towards achieving global targets, WHO and the United Nations Children's Fund (UNICEF) have developed standards for improving the quality of SSNC in health facilities and a model of level-2 care for SSNBs.

This session will feature global innovators presenting innovative CPAP decision-making tools, three categories of CPAP devices, and in-country user experiences from patient, parent, and health care provider perspectives.